Social networks
219 10,610Global tags
Activities
Technologies
Entity types
Location
65 Av. Jules Cantini, 13006 Marseille, France
Marseille
France
Employees
Scale: 51-200
Estimated: 133
SIREN
474510013Engaged corporates
14Added in Motherbase
3 years, 4 months agoOur Mission : Leverage Artificial Intelligence to revolutionize interventional cardiac electrophysiology.
Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine and deep learning algorithms to assist operators during cardiac ablation procedures.
Volta’s DNA is to provide physicians with solutions that are user-friendly. Its first medical device, VX1, consists of a cue-giving interface designed to facilitate the identification of abnormal electrograms during ablation of complex arrhythmias such as atrial fibrillation. With VX1, operators keep their go-to navigation system and catheters.
The VX1 real-time analysis algorithm has been trained on carefully curated databases of annotated intra-cardiac electrograms. The solution may be used as a support to assist electrogram-based atrial fibrillation ablation.
VX1 is CE marked and FDA cleared. VX1 was the first artificial intelligence-based software solution to be FDA cleared in the interventional cardiology space.
Volta Medical is expanding at a fast rate across the globe. Multiple partnerships have been formed with leading centers in Europe and the US.
Medical Device, Machine Learning, Deep Learning, Cardiac Electrophysiology, MedTech, atrial Fibrillation, and Software
Our Mission : Leverage Artificial Intelligence to revolutionize interventional cardiac electrophysiology.
Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine and deep learning algorithms to assist operators during cardiac ablation procedures.
Volta’s DNA is to provide physicians with solutions that are user-friendly. Its first medical device, VX1, consists of a cue-giving interface designed to facilitate the identification of abnormal electrograms during ablation of complex arrhythmias such as atrial fibrillation. With VX1, operators keep their go-to navigation system and catheters.
The VX1 real-time analysis algorithm has been trained on carefully curated databases of annotated intra-cardiac electrograms. The solution may be used as a support to assist electrogram-based atrial fibrillation ablation.
VX1 is CE marked and FDA cleared. VX1 was the first artificial intelligence-based software solution to be FDA cleared in the interventional cardiology space.
Volta Medical is expanding at a fast rate across the globe. Multiple partnerships have been formed with leading centers in Europe and the US.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Ventech Finance, Venture Capital and Private Equity Principals | Ventech Finance, Venture Capital and Private Equity Principals | Other 16 Oct 2024 | | |
France Digitale Startup accelerator & VC, Non-profit Organizations | France Digitale Startup accelerator & VC, Non-profit Organizations | Other 24 Sep 2024 | | |
HEC Paris MBA Higher Education | HEC Paris MBA Higher Education | Other 4 Jul 2024 | | |
Groupe Crédit Agricole Bank, Banking | Groupe Crédit Agricole Bank, Banking | Other 18 Jun 2024 | | |
Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 29 Oct 2023 | | |
Caisse d’Epargne Banking | Caisse d’Epargne Banking | Other 23 Jul 2023 | | |
La Tribune Media, Newspapers | La Tribune Media, Newspapers | Other 6 Jan 2023 | | |
Le Journal des Entreprises Media, Newspaper Publishing | Le Journal des Entreprises Media, Newspaper Publishing | Other 16 Feb 2023 | | |
Avolta Finance, Investment Banking | Avolta Finance, Investment Banking | Other 10 Jan 2023 | | |
La French Tech Aix-Marseille Région Sud French Tech, Software Development | La French Tech Aix-Marseille Région Sud French Tech, Software Development | Other 6 Jan 2023 7 Oct 2024 | | |